# The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)

> **NCT00401869** · PHASE4 · COMPLETED · sponsor: **Ortho Biotech, Inc.** · enrollment: 289 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Epoetin alfa

## Key facts

- **NCT ID:** NCT00401869
- **Lead sponsor:** Ortho Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** —
- **Final completion:** 2001-12
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2010-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401869, "The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00401869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*